💨 Abstract

A new blood test called MiONCO-Dx, which detects microRNA to identify early-stage cancers including bowel cancer, is being assessed in a government-backed clinical trial. If successful, it could replace invasive bowel cancer screening methods on the NHS, potentially saving thousands of lives. The test has 99% accuracy and could help reduce cancer-related deaths by early detection.

Courtesy: metro.co.uk

Summarized by Einstein Beta 🤖